These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3667273)
21. Use of faecal excretion function for quick estimation of initial and existing lung burden for occupational exposure control due to 239Pu for S-class of intake. Yadav JR; Rao DD; Hegde AG; Aggarwal SK Radiat Prot Dosimetry; 2008; 129(4):403-10. PubMed ID: 18083719 [TBL] [Abstract][Full Text] [Related]
22. Estimating 241Am activity in the body: comparison of direct measurements and radiochemical analyses. Lynch TP; Tolmachev SY; James AC Radiat Prot Dosimetry; 2009 Jun; 134(2):94-101. PubMed ID: 19470448 [TBL] [Abstract][Full Text] [Related]
23. Distribution of plutonium particles in the lungs of Mayak workers. Hahn FF; Romanov SA; Guilmette RA; Nifatov AP; Zaytseva YV; Diel JH; Allen SW; Lyovkina YV Radiat Prot Dosimetry; 2003; 105(1-4):81-4. PubMed ID: 14526932 [TBL] [Abstract][Full Text] [Related]
24. Modifying effects of health status, physiological, and dosimetric factors on extrapulmonary organ distribution and excretion of inhaled plutonium in workers at the Mayak Production Association. Suslova KG; Khokhryakov VF; Tokarskaya ZB; Nifatov AP; Sokolova AB; Miller SC; Krahenbuhl MP Health Phys; 2006 Apr; 90(4):299-311. PubMed ID: 16538136 [TBL] [Abstract][Full Text] [Related]
25. An analysis of a puncture wound case with medical intervention. Bailey BR; Eckerman KF; Townsend LW Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019 [TBL] [Abstract][Full Text] [Related]
26. Plutonium in the Ozyorsk population. Suslova KG; Khokhryakov VF; Sokolova AB Radiat Prot Dosimetry; 2007; 127(1-4):502-6. PubMed ID: 17545660 [TBL] [Abstract][Full Text] [Related]
27. Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): pharmacokinetics and oral efficacy. Durbin PW; Kullgren B; Xu J; Raymond KN; Hengé-Napoli MH; Bailly T; Burgada R Radiat Prot Dosimetry; 2003; 105(1-4):503-8. PubMed ID: 14527018 [TBL] [Abstract][Full Text] [Related]
28. Two case studies of highly insoluble plutonium inhalation with implications for bioassay. Carbaugh EH; La Bone TR Radiat Prot Dosimetry; 2003; 105(1-4):133-8. PubMed ID: 14526943 [TBL] [Abstract][Full Text] [Related]
29. Modifying the ICRP 66 dosimetry model based on results obtained from Mayak plutonium workers. Romanov SA; Guilmette RA; Hahn FF; Nifatov AP; Zaytseva YV; Lyovkina YV Radiat Prot Dosimetry; 2003; 105(1-4):85-90. PubMed ID: 14526933 [TBL] [Abstract][Full Text] [Related]
30. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy. Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097 [TBL] [Abstract][Full Text] [Related]
31. Comparison of dose estimation from occupational exposure to 239Pu using different modelling approaches. Romanov SA; Guilmette RA; Khokhryakov VF; Phipps A; Aladova EE; Bertelli L; Birchall A; Eckerman KF; Khokhryakov VV; Krahenbuhl MP; Leggett RW; Little TT; Miller G; Miller SC; Riddell A; Suslova KG; Vostrotin VV; Zaytseva YV Radiat Prot Dosimetry; 2007; 127(1-4):486-90. PubMed ID: 18045798 [TBL] [Abstract][Full Text] [Related]
32. Anomalously high excretion of Pu in urine following inhalation of plutonium nitrate? Etherington G; Stradling GN; Hodgson A; Fifield LK Radiat Prot Dosimetry; 2003; 105(1-4):321-4. PubMed ID: 14526978 [TBL] [Abstract][Full Text] [Related]
33. Extrapulmonary organ distribution of plutonium in healthy workers exposed by chronic inhalation at the Mayak production association. Suslova KG; Khokhryakov VF; Tokarskaya ZB; Nifatov AP; Krahenbuhl MP; Miller SC Health Phys; 2002 Apr; 82(4):432-44. PubMed ID: 11906132 [TBL] [Abstract][Full Text] [Related]
35. 238Pu: accumulation, tissue distribution, and excretion in Mayak workers after exposure to plutonium aerosols. Suslova KG; Sokolova AB; Khokhryakov VV; Miller SC Health Phys; 2012 Mar; 102(3):243-50. PubMed ID: 22420016 [TBL] [Abstract][Full Text] [Related]
36. Mayak Worker Dosimetry System 2008 (MWDS-2008): assessment of internal dose from measurement results of plutonium activity in urine. Khokhryakov VV; Khokhryakov VF; Suslova KG; Vostrotin VV; Vvedensky VE; Sokolova AB; Krahenbuhl MP; Birchall A; Miller SC; Schadilov AE; Ephimov AV Health Phys; 2013 Apr; 104(4):366-78. PubMed ID: 23439140 [TBL] [Abstract][Full Text] [Related]
37. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium. Gervelas C; Serandour AL; Geiger S; Grillon G; Fritsch P; Taulelle C; Le Gall B; Benech H; Deverre JR; Fattal E; Tsapis N J Control Release; 2007 Mar; 118(1):78-86. PubMed ID: 17241685 [TBL] [Abstract][Full Text] [Related]
38. Influence of DTPA Treatment on Internal Dose Estimates. Davesne E; Blanchardon E; Peleau B; Correze P; Bohand S; Franck D Health Phys; 2016 Jun; 110(6):551-7. PubMed ID: 27115221 [TBL] [Abstract][Full Text] [Related]
39. [Effect of liposome-encapsulated pentacin on plutonium-239 excretion]. Il'in LA; Ivannikov AT; Altukhova GA; Parfenova IM; Chelysheva TV Radiobiologiia; 1989; 29(2):197-201. PubMed ID: 2717714 [TBL] [Abstract][Full Text] [Related]
40. Metabolism and dosimetry of actinide elements in occupationally-exposed personnel of Russia and the United States: a summary progress report. Khokhryakov VF; Suslova KG; Filipy RE; Alldredge JR; Aladova EE; Glover SE; Vostrotin VV Health Phys; 2000 Jul; 79(1):63-71. PubMed ID: 10855779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]